The natural anticancer compound rocaglamide selectively inhibits the G1‐S‐phase transition in cancer cells through the ATM/ATR‐mediated Chk1/2 cell cycle checkpoints
Publisher: John Wiley & Sons Inc
E-ISSN: 1097-0215|134|8|1991-2002
ISSN: 0020-7136
Source: INTERNATIONAL JOURNAL OF CANCER, Vol.134, Iss.8, 2014-04, pp. : 1991-2002
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract